Name: UMIN ID:
Unique ID issued by UMIN | UMIN000022008 |
---|---|
Receipt number | R000025358 |
Scientific Title | (C-SHOT1601)Phase II study of bortezomib plus Lenalidomide and dexamethasone (Once weekly BLd) for elderly or transplant-ineligible patients with untreated symptomatic multiple myeloma |
Date of disclosure of the study information | 2016/04/20 |
Last modified on | 2021/04/26 11:03:01 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/04/20 23:31:18 | ||
2 | Update | 2016/04/20 23:44:39 | Institutions |
|
3 | Update | 2016/04/20 23:46:29 | Institutions |
|
4 | Update | 2016/05/09 21:19:31 | UMIN ID1 |
|
5 | Update | 2016/05/09 21:21:31 | Email |
|
6 | Update | 2017/10/23 13:11:05 | Last name of contact person |
|
7 | Update | 2017/10/23 13:12:55 | Recruitment status Last follow-up date |
|
8 | Update | 2019/10/23 11:51:35 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
9 | Update | 2019/10/23 11:53:05 | Number of participants that the trial has enrolled |
|
10 | Update | 2019/10/23 11:55:15 | Date of IRB |
|
11 | Update | 2020/04/23 09:22:31 | Last follow-up date |
|
12 | Update | 2020/10/26 10:09:46 | Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
13 | Update | 2021/04/26 11:03:01 | Publication of results |